NCT03810235View on ClinicalTrials.gov

The OBstetric Lidocaine Patch (OBLido) Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

February 15, 2019

Primary Completion Date

September 9, 2019

Study Completion Date

November 30, 2019

Conditions
Pain, Postoperative
Interventions
DRUG

Transdermal Lidocaine Patch

Transdermal Lidocaine Patch

DRUG

Transdermal Hydrocolloid Placebo Patch

hydrocolloid placebo patches

Trial Locations (1)

53715

UnityPoint Health-Meriter Hospital, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER

NCT03810235 - The OBstetric Lidocaine Patch (OBLido) Trial | Biotech Hunter | Biotech Hunter